1. Rare diseases: considerations for the development of drugs and biological products : guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2023 Subject(s): Biological ProductsDrug DevelopmentDrug IndustryGovernment RegulationRare Diseases -- drug therapyUnited States